Khan T, Nagarajan M, Kang I, Wu C, Wangpaichitr M
J Pers Med. 2025; 15(2).
PMID: 39997327
PMC: 11856717.
DOI: 10.3390/jpm15020050.
Koppin A, Chase L
Int J Mol Sci. 2024; 25(19).
PMID: 39408599
PMC: 11476549.
DOI: 10.3390/ijms251910271.
Spinello I, Labbaye C, Saulle E
Int J Mol Sci. 2024; 25(17).
PMID: 39273126
PMC: 11395103.
DOI: 10.3390/ijms25179178.
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T
Sci Rep. 2024; 14(1):17917.
PMID: 39095551
PMC: 11297167.
DOI: 10.1038/s41598-024-68779-9.
Park E, Kim H, Yoon S, Jang B
Histol Histopathol. 2024; 39(12):1557-1564.
PMID: 38695393
DOI: 10.14670/HH-18-749.
Integrated functional screens and multi-omics analyses identify α-2,3-sialylation as essential for melanoma maintenance.
Agrawal P, Chen S, de Pablos A, Jame-Chenarboo F, Miera Saenz de Vega E, Darvishian F
bioRxiv. 2024; .
PMID: 38559078
PMC: 10979837.
DOI: 10.1101/2024.03.08.584072.
The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
Lee K, Seo E, Lee J, Kim H, Hwangbo C
Int J Mol Sci. 2023; 24(11).
PMID: 37298370
PMC: 10253468.
DOI: 10.3390/ijms24119418.
Transporter-Mediated Drug Delivery.
Gyimesi G, Hediger M
Molecules. 2023; 28(3).
PMID: 36770817
PMC: 9919865.
DOI: 10.3390/molecules28031151.
Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation.
Bouthelier A, Fernandez-Arroyo L, Mesa-Ciller C, Cibrian D, Martin-Cofreces N, Castillo-Gonzalez R
iScience. 2022; 26(1):105739.
PMID: 36582828
PMC: 9792907.
DOI: 10.1016/j.isci.2022.105739.
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
Yang Y, Bolomsky A, Oellerich T, Chen P, Ceribelli M, Haupl B
Nat Commun. 2022; 13(1):5469.
PMID: 36115844
PMC: 9482638.
DOI: 10.1038/s41467-022-33142-x.
N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98).
Console L, Scalise M, Salerno S, Scanga R, Giudice D, Bartolo L
Sci Rep. 2022; 12(1):14570.
PMID: 36028562
PMC: 9418156.
DOI: 10.1038/s41598-022-18779-4.
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer.
Carlos Montero J, Calvo-Jimenez E, Carmen S, Abad M, Ocana A, Pandiella A
J Exp Clin Cancer Res. 2022; 41(1):106.
PMID: 35317825
PMC: 8941813.
DOI: 10.1186/s13046-022-02330-4.
CD98hc has a pivotal role in maintaining the immuno-barrier integrity of basal layer cells in esophageal epithelium.
Ye H, Li X, Lin J, Yang P, Su M
Cancer Cell Int. 2022; 22(1):98.
PMID: 35193580
PMC: 8864845.
DOI: 10.1186/s12935-021-02399-5.
Bioactive peptides from broccoli stems strongly enhance regenerative keratinocytes by stimulating controlled proliferation.
Nicolas-Espinosa J, Yepes-Molina L, Carvajal M
Pharm Biol. 2022; 60(1):235-246.
PMID: 35086428
PMC: 8797740.
DOI: 10.1080/13880209.2021.2009522.
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.
Pellizzari G, Martinez O, Crescioli S, Page R, Di Meo A, Mele S
J Immunother Cancer. 2021; 9(6).
PMID: 34112739
PMC: 8194339.
DOI: 10.1136/jitc-2020-002140.
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K
Sci Rep. 2021; 11(1):11478.
PMID: 34075107
PMC: 8169706.
DOI: 10.1038/s41598-021-90748-9.
SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin W, Wang C, Liu G, Bi C, Wang X, Zhou Q
Am J Cancer Res. 2020; 10(10):3106-3126.
PMID: 33163260
PMC: 7642655.
LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM.
Chiduza G, Johnson R, Wright G, Antonyuk S, Muench S, Hasnain S
Acta Crystallogr D Struct Biol. 2019; 75(Pt 7):660-669.
PMID: 31282475
PMC: 7285653.
DOI: 10.1107/S2059798319009094.
Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity.
Terrinoni M, Holmgren J, Lebens M, Larena M
Sci Rep. 2019; 9(1):2812.
PMID: 30808871
PMC: 6391456.
DOI: 10.1038/s41598-019-38726-0.
The prion protein is embedded in a molecular environment that modulates transforming growth factor β and integrin signaling.
Ghodrati F, Mehrabian M, Williams D, Halgas O, Bourkas M, Watts J
Sci Rep. 2018; 8(1):8654.
PMID: 29872131
PMC: 5988664.
DOI: 10.1038/s41598-018-26685-x.
